I
IMPACT Therapeutics
Biotech & Life Sciences · Nanjing City, China · Founded 2009
IMPACT Therapeutics is a China based Company MoreLess
Impact Therapeutics is a biopharmaceutical company focused on developing innovative cancer therapies. The company operates in the oncology market, targeting both patients and healthcare providers. Its business model revolves around the discovery and clinical translation of novel drugs designed to treat various forms of cancer. By integrating drug discovery with clinical trials, Impact Therapeutics aims to bring effective treatments to market more efficiently. The company generates revenue through partnerships, licensing agreements, and the commercialization of its proprietary drugs. Key clients include hospitals, cancer treatment centers, and pharmaceutical companies. Impact Therapeutics leverages its expertise in personalized cancer therapy to improve patient outcomes and advance the field of oncology.
Keywords: cancer therapy, drug discovery, clinical trials, oncology, biopharmaceutical, personalized medicine, healthcare, innovation, patient outcomes, partnerships.
Company overview
IMPACT Therapeutics company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2009
- Headquarters
- Nanjing City, China
- Employees
- —
- Open positions
- 1
- Dealroom signal
- 25.3
Valuation & funding
IMPACT Therapeutics funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPOOther financing | May 2026 | $102M | $726M | Undisclosed | ↗ |
| SERIES DOther financing | Nov 2024 | $34M | $756M | Undisclosed | ↗ |
| SERIES DOther financing | Apr 2024 | $55M | $691M | Xiamen C&D · Yu Yuanyong · Yangzhou Guojinyingpin Biomedical Venture Investment Partnership · Lilly Asia Ventures | ↗ |
| SERIES DOther financing | Mar 2022 | — | — | Beijing Dingxin Capital · Bestride · China Summit Capital · Exome Asset Management | ↗ |
| SERIES COther financing | Dec 2020 | $50M | $200M | Shanghai Junshi Biosciences | — |
| SERIES COther financing | Aug 2018 | Decheng Capital | — | ||
| SERIES BOther financing | Feb 2016 | Lilly Asia Ventures · Summit Capital · Yuansheng BioVenture | — | ||
| SERIES AOther financing | Jul 2014 | Lilly Asia Ventures · Cenova Capital · WuXi Healthcare Ventures | — |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $34M | +537.8% | −$17M | -50.7% |
| 2025 | $5.3M | +14% | — | — |
| 2024 | $4.6M | -85.7% | — | — |
| 2023 | $32M | — | — | — |
Growth signals
IMPACT Therapeutics website traffic
Latest recorded traffic for IMPACT Therapeutics is 650 monthly website visits, up 47.7% over the last three months.
Hiring
Open positions at IMPACT Therapeutics
Current openings linked to this company in Dealroom.
Comparisons
IMPACT Therapeutics compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
IMPACT Therapeutics's talent
Source: Dealroom Talent Intelligence.
Investors
20 investors on IMPACT Therapeutics's cap table
Sourced from Dealroom's funding and investor records.
Global footprint
Where IMPACT Therapeutics has talent and traffic
team presence
In the news
Latest news about IMPACT Therapeutics
Recent press, funding announcements, and product moves mentioning IMPACT Therapeutics — open to read from the original sources.
Market sentiment
What the market is saying about IMPACT Therapeutics
An AI-synthesized read of the highest-engagement posts about IMPACT Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IMPACT Therapeutics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.